News in English

ADC Therapeutics touts early Zynlonta results in marginal zone lymphoma, raises $105M through share sale

ADC Therapeutics touts early Zynlonta results in marginal zone lymphoma, raises $105M through share sale esagonowsky

Читайте на сайте